260 related articles for article (PubMed ID: 8032367)
1. Lymphoproliferative disorders and other tumors complicating immunodeficiencies.
Filipovich AH; Mathur A; Kamat D; Kersey JH; Shapiro RS
Immunodeficiency; 1994; 5(2):91-112. PubMed ID: 8032367
[TBL] [Abstract][Full Text] [Related]
2. Relationship of immunodeficiency to lymphoid malignancy.
Kersey JH; Shapiro RS; Filipovich AH
Pediatr Infect Dis J; 1988 May; 7(5 Suppl):S10-2. PubMed ID: 2840629
[TBL] [Abstract][Full Text] [Related]
3. Immunoregulatory abnormalities in patients with Epstein-Barr virus-associated B cell lymphoproliferative disorders.
Mathur A; Kamat DM; Filipovich AH; Steinbuch M; Shapiro RS
Transplantation; 1994 Apr; 57(7):1042-5. PubMed ID: 8165700
[TBL] [Abstract][Full Text] [Related]
4. Lymphoproliferative disorders associated with congenital immunodeficiencies.
Elenitoba-Johnson KS; Jaffe ES
Semin Diagn Pathol; 1997 Feb; 14(1):35-47. PubMed ID: 9044508
[TBL] [Abstract][Full Text] [Related]
5. Primary cutaneous Epstein-Barr virus-related lymphoproliferative disorders in 4 immunosuppressed children.
Wallet-Faber N; Bodemer C; Blanche S; Delabesse E; Eschard C; Brousse N; Fraitag S
J Am Acad Dermatol; 2008 Jan; 58(1):74-80. PubMed ID: 17884243
[TBL] [Abstract][Full Text] [Related]
6. Prevention and treatment of Epstein-Barr virus (EBV)-associated lymphoproliferative diseases in immune deficient patients.
Purtilo DT
AIDS Res; 1986 Dec; 2 Suppl 1():S177-81. PubMed ID: 2435295
[TBL] [Abstract][Full Text] [Related]
7. Immunodeficiency-associated lymphomas.
Tran H; Nourse J; Hall S; Green M; Griffiths L; Gandhi MK
Blood Rev; 2008 Sep; 22(5):261-81. PubMed ID: 18456377
[TBL] [Abstract][Full Text] [Related]
8. Primary immunodeficiencies: genetic risk factors for lymphoma.
Filipovich AH; Mathur A; Kamat D; Shapiro RS
Cancer Res; 1992 Oct; 52(19 Suppl):5465s-5467s. PubMed ID: 1327508
[TBL] [Abstract][Full Text] [Related]
9. Human herpesvirus 6 in human immunodeficiency virus-infected individuals: association with early histologic phases of lymphadenopathy syndrome but not with malignant lymphoproliferative disorders.
Dolcetti R; Di Luca D; Carbone A; Mirandola P; De Vita S; Vaccher E; Sighinolfi L; Gloghini A; Tirelli U; Cassai E; Boiocchi M
J Med Virol; 1996 Apr; 48(4):344-53. PubMed ID: 8699167
[TBL] [Abstract][Full Text] [Related]
10. Benign and malignant Epstein-Barr virus-associated B-cell lymphoproliferative diseases.
Cohen JI
Semin Hematol; 2003 Apr; 40(2):116-23. PubMed ID: 12704588
[TBL] [Abstract][Full Text] [Related]
11. Immunodeficiency as a factor in lymphomagenesis.
Purtilo DT; Sakamoto K
Perspect Pediatr Pathol; 1984; 8(2):181-91. PubMed ID: 6330665
[TBL] [Abstract][Full Text] [Related]
12. Therapy for transplant-related lymphoproliferative diseases.
Benkerrou M; Durandy A; Fischer A
Hematol Oncol Clin North Am; 1993 Apr; 7(2):467-75. PubMed ID: 8385662
[TBL] [Abstract][Full Text] [Related]
13. [Lymphomas in immunocompromised hosts].
Berger F; Delecluse HJ
Rev Prat; 1993 Sep; 43(13):1661-4. PubMed ID: 8303184
[TBL] [Abstract][Full Text] [Related]
14. Immunodeficiency-associated lymphoproliferative disorders.
Knowles DM
Mod Pathol; 1999 Feb; 12(2):200-17. PubMed ID: 10071343
[TBL] [Abstract][Full Text] [Related]
15. Depressed immunity and the development of cancer.
Penn I
Cancer Detect Prev; 1994; 18(4):241-52. PubMed ID: 7982234
[TBL] [Abstract][Full Text] [Related]
16. Lymphoma after solid organ transplantation: risk, response to therapy, and survival at a transplantation center.
Knight JS; Tsodikov A; Cibrik DM; Ross CW; Kaminski MS; Blayney DW
J Clin Oncol; 2009 Jul; 27(20):3354-62. PubMed ID: 19451438
[TBL] [Abstract][Full Text] [Related]
17. Epstein-Barr virus-associated B cell lymphoproliferative disorder following mismatched related T cell-depleted bone marrow transplantation.
Chiang KY; Hazlett LJ; Godder KT; Abhyankar SH; Christiansen NP; van Rhee F; Lee CG; Bridges K; Parrish RS; Henslee-Downey PJ
Bone Marrow Transplant; 2001 Dec; 28(12):1117-23. PubMed ID: 11803352
[TBL] [Abstract][Full Text] [Related]
18. Hodgkin's disease-like lymphoproliferative disorders in patients with different underlying immunodeficiency states.
Tinguely M; Vonlanthen R; Müller E; Dommann-Scherrer CC; Schneider J; Laissue JA; Borisch B
Mod Pathol; 1998 Apr; 11(4):307-12. PubMed ID: 9578079
[TBL] [Abstract][Full Text] [Related]
19. Complete immunosuppressive withdrawal as a uniform approach to post-transplant lymphoproliferative disease in pediatric liver transplantation.
Hurwitz M; Desai DM; Cox KL; Berquist WE; Esquivel CO; Millan MT
Pediatr Transplant; 2004 Jun; 8(3):267-72. PubMed ID: 15176965
[TBL] [Abstract][Full Text] [Related]
20. Analysis of the T-cell micro-environment in Epstein-Barr virus-related post-transplantation B lymphoproliferative disease.
Perera SM; Thomas JA; Burke M; Crawford DH
J Pathol; 1998 Feb; 184(2):177-84. PubMed ID: 9602709
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
